Table 1 Baseline clinical and laboratory data
Total of patients included: n = 60 | |
|---|---|
Clinical characteristics | |
Age, years | 73.5 (36.0–84.0) (IQR = 8.8) |
Male | 27 (45%) |
BSA, m2 | 1.78 ± 0.17 |
Hypertension | 48 (80.0%) |
Diabetes mellitus | 17 (28.3%) |
Dyslipidemia | 34 (56.7%) |
Smoking history | 13 (21.7%) |
Previous stroke | 1 (1.7%) |
Atrial fibrillation | 7 (11.7%) |
Previous pacemaker implantation | 0 (0.0%) |
NYHA functional class | |
I | 1 (0.8%) |
II | 42 (35.3%) |
III | 17 (14.3%) |
Anginal symptoms | 13 (10.9%) |
Syncope | 14 (11.8%) |
Laboratory results | |
Htc, % | 39.3 ± 3.1 |
Creatinin, mg/dL | 0.91 (0.58–2.26) |
Estimated glomerular filtration rate, mL/min | 71.47 ± 26.09 |
NT-proBNP, pg/mL | 561.0 (41.0–22664.0) |
Troponin I, ng/L | 16.2 (0-115) |